000 | 01927 a2200493 4500 | ||
---|---|---|---|
005 | 20250516045959.0 | ||
264 | 0 | _c20120605 | |
008 | 201206s 0 0 eng d | ||
022 | _a1097-0215 | ||
024 | 7 |
_a10.1002/ijc.26284 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTsui, Ke-Hung | |
245 | 0 | 0 |
_aUpregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells. _h[electronic resource] |
260 |
_bInternational journal of cancer _cJun 2012 |
||
300 |
_a2812-23 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCell Cycle Proteins _xbiosynthesis |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aG1 Phase Cell Cycle Checkpoints _xdrug effects |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmediate-Early Proteins _xbiosynthesis |
650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xgenetics |
650 | 0 | 4 |
_aLuteolin _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aNeoplasm Invasiveness |
650 | 0 | 4 |
_aPromoter Regions, Genetic _xdrug effects |
650 | 0 | 4 |
_aProstate _xmetabolism |
650 | 0 | 4 |
_aProstate-Specific Antigen _xbiosynthesis |
650 | 0 | 4 |
_aProstatic Neoplasms _xgenetics |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-ets _xbiosynthesis |
650 | 0 | 4 |
_aReceptors, Androgen _xbiosynthesis |
650 | 0 | 4 |
_aSerpins _xbiosynthesis |
650 | 0 | 4 | _aTranscriptional Activation |
650 | 0 | 4 |
_aTumor Suppressor Proteins _xbiosynthesis |
700 | 1 | _aChung, Li-Chuan | |
700 | 1 | _aFeng, Tsui-Hsia | |
700 | 1 | _aChang, Phei-Lang | |
700 | 1 | _aJuang, Horng-Heng | |
773 | 0 |
_tInternational journal of cancer _gvol. 130 _gno. 12 _gp. 2812-23 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/ijc.26284 _zAvailable from publisher's website |
999 |
_c21026963 _d21026963 |